Late endosomal trafficking of alternative serotype adenovirus vaccine vectors Augments antiviral innate immunity

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10354-10363

  Teigler, Jeffrey E ^a   Kagan, Jonathan C ^b   Barouch, Dan H ^a,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA2 INTERFERON; CATHEPSIN B; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACIDIFICATION; ADENOVIRUS; ADENOVIRUS 26; ADENOVIRUS 35; ANTIGEN RECOGNITION; ARTICLE; CELL COMPARTMENTALIZATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; INNATE IMMUNITY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VIRUS CELL INTERACTION; VIRUS PARTICLE; CLASSIFICATION; GENE VECTOR; GENETICS; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS INFECTION; IMMUNOLOGY; VIROLOGY;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ENDOSOMES; GENETIC VECTORS; HUMANS; IMMUNITY, INNATE; SEROGROUP;

EID: 84906351273     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00936-14     Document Type: Article

References (42)

1. Abbink P, Lemckert AAC, Ewald BA, Lynch DM, Denholtz M, Smits S, Holterman L, Damen I, Vogels R, Thorner AR, Brien KLO, Carville A, Mansfield KG, Goudsmit J, Havenga MJE, Barouch DH. 2007. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 81: 4654-4663. http://dx.doi.org/10.1128/JVI.02696-06.
2. Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker L-G, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG, Pau MG, Goudsmit J. 2011. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine 29: 5203-5209. http://dx.doi.org/10.1016/j.vaccine.2011.05.025.
3. Santra S, Sun Y, Korioth-Schmitz B, Fitzgerald J, Charbonneau C, Santos G, Seaman MS, Ratcliffe SJ, Montefiori DC, Nabel GJ, Ertl HCJ, Letvin NL. 2009. Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors. Vaccine 27:5837-5845. http://dx.doi.org/10.1016/j.vaccine.2009.07.050.
4. Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, Landucci G, Forthal DN, Montefiori DC, Carville A, Mansfield KG, Havenga MJ, Pau MG, Goudsmit J, Barouch DH. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457:87-91. http://dx.doi .org/10.1038/nature07469.
5. Penaloza-MacMaster P, Provine NM, Ra J, Borducchi EN, McNally A, Simmons NL, Iampietro MJ, Barouch DH. 2013. Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors. J. Virol. 87:1373-1384. http://dx.doi .org/10.1128/JVI.02058-12.
6. Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G, Forthal DN, Ourmanov I, Hirsch VM, Carville A, Mansfield KG, Stablein D, Pau MG, Schuitemaker H, Sadoff JC, Billings EM, Rao M, Robb ML, Kim JH, Marovich MA, Goudsmit J, Michael NL. 2012. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 482:89-93. http://dx.doi.org/10.1038/nature10766.
7. Letvin NL, Rao SS, Montefiori DC, Seaman MS, Sun Y, Lim S-Y, Yeh WW, Asmal M, Gelman RS, Shen L, Whitney JB, Seoighe C, Lacerda M, Keating S, Norris PJ, Hudgens MG, Gilbert PB, Buzby AP, Mach LV, Zhang J, Balachandran H, Shaw GM, Schmidt SD, Todd J-P, Dodson A, Mascola JR, Nabel GJ. 2011. Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys. Sci. Transl. Med. 3:81ra36. http://dx.doi.org/10.1126/scitranslmed.3002351.
8. Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, Nakaya HI, Ravindran R, Stewart S, Alam M, Kwissa M, Villinger F, Murthy N, Steel J, Jacob J, Hogan RJ, García-Sastre A, Compans R, Pulendran B. 2011. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470:543-547. http://dx.doi.org/10.1038 /nature09737.
9. Manicassamy S, Pulendran B. 2009. Modulation of adaptive immunity with Toll-like receptors. Semin. Immunol. 21:185-193. http://dx.doi.org /10.1016/j.smim.2009.05.005.
10. Pulendran B. 2004. Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunol. Res. 29:187- 196. http://dx.doi.org/10.1385/IR:29:1-3:187.
11. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, Pirani A, Gernert K, Deng J, Marzolf B, Kennedy K, Wu H, Bennouna S, Oluoch H, Miller J, Vencio RZ, Mulligan M, Aderem A, Ahmed R, Pulendran B. 2009. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10:116-125. http: //dx.doi.org/10.1038/ni.1688.
12. Teigler JE, Iampietro MJ, Barouch DH. 2012. Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys. J. Virol. 86:9590- 9598. http://dx.doi.org/10.1128/JVI.00740-12.
13. Johnson MJ, Petrovas C, Yamamoto T, Lindsay RWB, Loré K, Gall JGD, Gostick E, Lefebvre F, Cameron MJ, Price D, Haddad E, Sekaly R-P, Seder R, Koup R. 2012. Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity. J. Imunol. 188: 6109-6118. http://dx.doi.org/10.4049/jimmunol.1103717.
14. Iacobelli-Martinez M, Nemerow GR. 2007. Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J. Virol. 81:1305- 1312. http://dx.doi.org/10.1128/JVI.01926-06.
15. Barlan AU, Danthi P, Wiethoff CM. 2011. Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology 412:306-314. http://dx.doi .org/10.1016/j.virol.2011.01.019.
16. Barlan U, Griffin TM, McGuire K, Wiethoff CM. 2011. Adenovirus membrane penetration activates the NLRP3 inflammasome. J. Virol. 85: 146-155. http://dx.doi.org/10.1128/JVI.01265-10.
17. Alba R, Bradshaw AC, Coughlan L, Denby L, McDonald R, Waddington SN, Buckley SMK, Greig JA, Parker AL, Miller AM, Wang H, Lieber A, van Rooijen N, McVey JH, Nicklin SA, Baker AH. 2010. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors. Blood 116:2656-2664. http://dx.doi.org/10.1182/blood-2009-12 -260026.
18. Gastaldelli M, Imelli N, Boucke K, Amstutz B, Meier O, Greber UF. 2008. Infectious adenovirus type 2 transport through early but not late endosomes. Traffic 9:2265-2278. http://dx.doi.org/10.1111/j.1600-0854 .2008.00835.x.
19. Kälin S, Amstutz B, Gastaldelli M, Wolfrum N, Boucke K, Havenga M, DiGennaro F, Liska N, Hemmi S, Greber UF. 2010. Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J. Virol. 84:5336-5350. http://dx.doi.org/10.1128/JVI.02494-09.
20. Leopold PL, Ferris B, Grinberg I, Worgall S, Hackett NR, Crystal RG. 1998. Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 9:367-378. http://dx .doi.org/10.1089/hum.1998.9.3-367.
21. Meier O, Boucke K, Hammer SV, Keller S, Stidwill RP, Hemmi S, Greber UF. 2002. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol. 158:1119- 1131. http://dx.doi.org/10.1083/jcb.200112067.
22. Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falckpedersen E, Crystal RG. 1999. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J. Virol. 73:6056-6065.
23. Miyazawa N, Crystal RG, Leopold PL. 2001. Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J. Virol. 75:1387-1400. http://dx.doi.org/10.1128 /JVI.75.3.1387-1400.2001.
24. Shayakhmetov DM, Li Z, Ternovoi V, Gaggar A, Gharwan H, Lieber A. 2003. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J. Virol. 77:3712-3723. http://dx.doi.org/10.1128/JVI.77.6 .3712-3723.2003.
25. Nanda A, Lynch DM, Goudsmit J, Angelique A, Lemckert C, Ewald BA, Sumida SM, Diana M, Abbink P, Kishko MG, Gorgone DA, Lifton MA, Shen L, Carville A, Keith G, Havenga MJE, Barouch DH, Lemckert AAC, Truitt DM, Mansfield KG. 2005. Immunogenicity of recombinant fiber-Chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys. J. Virol. 79:14161-14168. http://dx.doi.org/10.1128/JVI .79.22.14161-14168.2005.
26. Bennett S, Breit SN. 1994. Variables in the isolation and culture of human monocytes that are of particular relevance to studies of HIV. J. Leukoc. Biol. 56:236-240.
27. Chen JW, Murphy TL, Willingham MC, Pastan I, August JT. 1985. Identification of two lysosomal membrane glycoproteins. J. Cell Biol. 101: 85-95. http://dx.doi.org/10.1083/jcb.101.1.85.
28. Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld S. 1988. The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 52: 329-341. http://dx.doi.org/10.1016/S0092-8674(88)80026-6.
29. Mu F-T, Callaghan JM, Steele-Mortimer O, Stenmark H, Parton RG, Campbell PL, McCluskey J, Yeo J-P, Tock EP, Toh B-H. 1995. EEA1, an early endosome-associated protein. J. Biol. Chem. 270:13503-13511. http: //dx.doi.org/10.1074/jbc.270.22.13503.
30. Chandra J, McCormick TS, Imamura Y, Mukherjee PK, Ghannoum MA. 2007. Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines. Infect. Immun. 75:2612-2620. http://dx.doi.org/10.1128/IAI.01841-06.
31. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U. S. A. 101:5598-5603. http://dx.doi.org/10.1073/pnas.0400937101.
32. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520. http://dx.doi.org/10.1084 /jem.20030162.
33. Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, Turk D. 2012. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim. Biophys. Acta 1824:68-88. http://dx.doi.org/10.1016/j .bbapap.2011.10.002.
34. McIlwain, DR, Berger T, Mak TW. 2013. Caspase functions in cell death and disease. Cold Spring Harb. Perspect. Biol. 5:a008656. http://dx.doi .org/10.1101/cshperspect.a008656.
35. Pahl JHW, Verhoeven DHJ, Kwappenberg KMC, Vellinga J, Lankester AC, van Tol MJD, Schilham MW. 2012. Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling. Mol. Immunol. 51:91-100. http://dx.doi.org/10.1016/j .molimm.2012.02.119.
36. Zhu J, Huang X, Yang Y. 2007. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J. Virol. 81:3170-3180. http://dx.doi.org/10.1128/JVI .02192-06.
37. Perreau M, Welles HC, Pellaton C, Gjoksi B, Potin L, Martin R, Harari A, Bett A, Casimiro D, Gall J, Barouch DH, Kremer EJ, Pantaleo G. 2012. The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes. J. Virol. 86:6279-6285. http://dx.doi.org/10 .1128/JVI.00123-12.
38. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9:847-856. http://dx.doi.org/10.1038/ni.1631.
39. Lam E, Stein S, Falck-Pedersen E. 2013. Adenovirus detection by the cGAS/STING/TBK1 DNA sensing cascade. J. Virol. 88:974-981. http://dx .doi.org/10.1128/JVI.02702-13.
40. Rhee EG, Blattman JN, Kasturi SP, Kelley RP, Kaufman DR, Lynch DM, La Porte A, Simmons NL, Clark SL, Pulendran B, Greenberg PD, Barouch DH. 2011. Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors. J. Virol. 85: 315-323. http://dx.doi.org/10.1128/JVI.01597-10.
41. Greber UF, Willetts M, Webster P, Helenius A. 1993. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477-486. http://dx .doi.org/10.1016/0092-8674(93)90382-Z.
42. Manders EMM, Verbeek FJ, Aten JA. 1993. Measurement of colocalization of objects in dual-colour confocal images. J. Microsc. 169:375-382. http://dx.doi.org/10.1111/j.1365-2818.1993.tb03313.x.